Zobrazeno 1 - 10
of 14
pro vyhledávání: '"Fuminori Ohta"'
Autor:
Yumi Tanaka, Shoji Oura, Tatsuya Yoshimasu, Fuminori Ohta, Koma Naito, Rie Nakamura, Yoshimitsu Hirai, Masako Ikeda, Yoshitaka Okamura
Publikováno v:
Case Reports in Oncology, Vol 6, Iss 1, Pp 1-5 (2013)
A 62-year-old woman with breast cancer received neoadjuvant chemotherapy followed by breast-conserving surgery and sentinel node biopsy. During adjuvant endocrine therapy with aromatase inhibitor, she developed multiple bone metastases. Thereafter, s
Externí odkaz:
https://doaj.org/article/e70c81093c254111ad959bbd63868acd
Autor:
Tatsuya Yoshimasu, Masako Ikeda, Fuminori Ohta, Yoshimitsu Hirai, Koma Naito, Yumi Tanaka, Shoji Oura, Rie Nakamura, Yoshitaka Okamura
Publikováno v:
Case Reports in Oncology
Case Reports in Oncology, Vol 6, Iss 1, Pp 1-5 (2013)
Case Reports in Oncology, Vol 6, Iss 1, Pp 1-5 (2013)
A 62-year-old woman with breast cancer received neoadjuvant chemotherapy followed by breast-conserving surgery and sentinel node biopsy. During adjuvant endocrine therapy with aromatase inhibitor, she developed multiple bone metastases. Thereafter, s
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::4a98657369af9b9bb200e3cb120bc735
https://doi.org/10.1159/000345097
https://doi.org/10.1159/000345097
Publikováno v:
Nihon Rinsho Geka Gakkai Zasshi (Journal of Japan Surgical Association). 73:801-806
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::4a35ef7958af27380d0d07cf4a3bbb67
https://doi.org/10.3919/jjsa.73.801
https://doi.org/10.3919/jjsa.73.801
Autor:
Yoshitaka Okamura, Mitsumasa Kawago, Shoji Oura, Koma Naito, Sayoko Hashimoto, Haruka Nishiguchi, Tatsuya Yoshimasu, Fuminori Ohta, Yoshimitsu Hirai, Rie Nakamura
Publikováno v:
Journal of Thoracic Oncology. 6(10):1658-1662
Introduction A recent large randomized controlled trial revealed that patients with lung cancer with epidermal growth factor receptor (EGFR) mutations had better prognoses when treated with the EGFR-tyrosine kinase inhibitor, gefitinib, than with cyt
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f40af1deab51fdcfc04a8a95618f3580
Autor:
Fuminori Ohta, Yasuaki Naito, Kenji Matsuyama, Hirokazu Tanino, Shoji Oura, Teruhisa Sakurai, Tatsuya Yoshimasu
Publikováno v:
The Journal of the Japanese Association for Chest Surgery. 15:538-543
対象は, 16例で, 男性15例, 女性1例.年齢は平均56歳 (30-71) で, 組織型は, 扁平上皮癌6例, 腺癌3例, 腺扁平上皮癌が1例, 大細胞癌が1例, 1arge cell neuroendocrine carcinomaが1例, 不明が4例であった.肺尖
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::764f7f340357aa98e65d2abb9fe2bf70
https://doi.org/10.2995/jacsurg.15.538
https://doi.org/10.2995/jacsurg.15.538
Autor:
Yasuaki Naito, Yozo Kokawa, Hirokazu Tanino, Kenji Matsuyama, Fuminori Ohta, Teruhisa Sakurai, Shoji Oura, Takako Nakamura, Tatsuya Yoshimasu
Publikováno v:
Breast Cancer. 7:307-310
We evaluated the usefulness of bisphosphonate (BIS) monotherapy, the safety of rapid infusion of BIS and the efficacy of BIS-sequential therapy for bone metastases from breast cancer.Twenty-nine patients with bone metastasis or invasion were treated
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::44af91400d4943111195cb6b3207e9bd
https://doi.org/10.1007/bf02966395
https://doi.org/10.1007/bf02966395
Autor:
Kenji Matsuyama, Teruhisa Sakurai, Shoji Oura, Yasuaki Naito, Tatsuya Yoshimasu, Takako Nakamura, Fuminori Ohta
Publikováno v:
The Journal of the Japanese Association for Chest Surgery. 14:144-147
症例は54歳女性で, 検診時胸部X線検査で, 胸部異常陰影を指摘された.胸部X線検査にて, 左上縦隔に腫瘤陰影を認め, 気管は右方に著しく圧排されていた.CT検査にて, 左甲状腺から左後縦隔
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::9634f3794985d9ef30b98db8acc7df74
https://doi.org/10.2995/jacsurg.14.144
https://doi.org/10.2995/jacsurg.14.144
Autor:
Koma, Naito, Shoji, Oura, Tatsuya, Yoshimasu, Takeshi, Tamaki, Fuminori, Ohta, Rie, Nakamura, Yukio, Shimizu, Megumi, Kiyoi, Yoshimistu, Hirai, Miwako, Miyasaka, Yoshitaka, Okamura
Publikováno v:
Gan to kagaku ryoho. Cancerchemotherapy. 36(2)
The efficacy and safety of primary systemic therapy with weekly paclitaxel (wPTX; 80 mg/m2) followed by FEC100 (cyclophosphamide 500 mg/m2, epirubicin 100 mg/m2, 5-fluorouracil 500 mg/m2)were investigated in 52 patients with stage I-III A locally adv
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::34c5906af7bf23cf1ccd41b135c50b36
https://pubmed.ncbi.nlm.nih.gov/19223740
https://pubmed.ncbi.nlm.nih.gov/19223740
Autor:
Rie Nakamura, Shoji Oura, Tatsuya Yoshimasu, Issei Hirai, Takeshi Tamaki, Fuminori Ohta, Yoshitaka Okamura
Publikováno v:
Breast cancer (Tokyo, Japan). 14(1)
Non-surgical ablation is an attractive approach as a local control method for breast cancer. The purpose of this study was to investigate the complications and efficacy of radiofrequency ablation (RFA) therapy for breast cancer.A total of 52 patients
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::1e3ed2fc328bcd93dd3ae4c9d52c65aa
https://pubmed.ncbi.nlm.nih.gov/17244994
https://pubmed.ncbi.nlm.nih.gov/17244994
Autor:
Tatsuya Yoshimasu, Koma Naito, Shoji Oura, Miwako Miyasaka, Yoshimitsu Hirai, Takeshi Tamaki, Fuminori Ohta
Publikováno v:
Cancer Research. 69:5153
Abstract #5153 Background: Radiofrequency ablation therapy (RFA) is one of the most minimally invasive approaches for the treatment of hepatic cancers and other solid malignancies. The aim of this study is to assess the safety and local controllabili
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::812a2d832b201cf0ddbf7894255b8e88
https://doi.org/10.1158/0008-5472.sabcs-5153
https://doi.org/10.1158/0008-5472.sabcs-5153